On September 8, 2021 Cyclacel Pharmaceuticals, Inc. (NASDAQ: CYCC, NASDAQ: CYCCP; "Cyclacel" or the "Company"), a biopharmaceutical company developing innovative medicines based on cancer cell biology, reported that the Company will participate in three investor conferences in September (Press release, Cyclacel, SEP 8, 2021, View Source [SID1234587418]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Presentation details are:

H.C. Wainwright 23rd Annual Global Investment Conference – September 13-15, 2021
Format: On demand presentation and 1X1 meetings
Date and Time: Available from Monday, September 13th 7am ET
Registration Link
Oppenheimer Fall Healthcare Life Sciences and MedTech Summit – September 20-22, 2021
Format: Presentation and 1X1 meetings
Date and Time: Tuesday, September 21, 10:45 AM ET
Webcast Link: View Source
Cantor Fitzgerald Global Healthcare Conference – September 27-30, 2021
Format: Presentation and 1X1 meetings
Date and Time: Thursday, September 30, 2:00 PM ET
Webcast Link: View Source
For the live and archived webcast, please visit the Corporate Presentations page on the Cyclacel website at www.cyclacel.com.